HAVCR2 and nasopharyngeal carcinoma: We suspect that immune-suppressive interaction of CD200-CD200R1 and LGALS9-HAVCR2 among LAMP3+ DCs, Treg cells, and exhausted CD8+ T cells might be also potential immunotherapeutic targets for NPC.